Localized changes in GABA receptor-gated chloride channel in rat brain after long-term haloperidol: relation to vacuous chewing movements. 1997

T Sasaki, and J L Kennedy, and J N Nobrega
Neurogenetics Research Section, Clarke Institute of Psychiatry, Toronto, Canada.

Several lines of evidence suggest that the GABAergic system may be involved in dyskinetic side effects of long-term neuroleptic treatment. In this study, [35S]TBPS autoradiography was used to investigate changes in the GABA receptor-gated chloride ionophore in rats showing vacuous chewing movements (VCMs) after 21 weeks of treatment with haloperidol decanoate (HAL). A significant decrease in [35S]TBPS binding was observed in the globus pallidus of HAL-treated rats, compared to vehicle-treated controls (+23%, P < 0.001). However, this was equally observed in rats showing high VCM levels (> 70 counts/5 min) and those showing low VCM levels (< 30 counts/5 min), suggesting that this pallidal change cannot account for the differential development of VCMs after long-term HAL. In contrast, a small but significant increase in [35S]TBPS binding in the ventrolateral caudate-putamen was seen in animals in the high VCM group (+16%, P < 0.03), but not in those in the low VCM group, when compared to vehicle-treated controls. No significant alterations were found in other basal ganglia regions and related structures, including the substantia nigra, subthalamic nucleus, entopeduncular nucleus, and thalamic nuclei. The results are consistent with the notion of altered striatopallidal output as a result of chronic HAL treatment. They also suggest the possibility that alterations in GABA receptor-linked Cl channels in the ventrolateral caudate-putamen may contribute to the development of dyskinetic syndromes after long-term neuroleptic treatment.

UI MeSH Term Description Entries
D008124 Locomotion Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms. Locomotor Activity,Activities, Locomotor,Activity, Locomotor,Locomotor Activities
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005247 Feeding Behavior Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals. Dietary Habits,Eating Behavior,Faith-based Dietary Restrictions,Feeding Patterns,Feeding-Related Behavior,Food Habits,Diet Habits,Eating Habits,Behavior, Eating,Behavior, Feeding,Behavior, Feeding-Related,Behaviors, Eating,Behaviors, Feeding,Behaviors, Feeding-Related,Diet Habit,Dietary Habit,Dietary Restriction, Faith-based,Dietary Restrictions, Faith-based,Eating Behaviors,Eating Habit,Faith based Dietary Restrictions,Faith-based Dietary Restriction,Feeding Behaviors,Feeding Pattern,Feeding Related Behavior,Feeding-Related Behaviors,Food Habit,Habit, Diet,Habit, Dietary,Habit, Eating,Habit, Food,Habits, Diet,Pattern, Feeding,Patterns, Feeding,Restrictions, Faith-based Dietary
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018079 Receptors, GABA Cell-surface proteins that bind GAMMA-AMINOBUTYRIC ACID with high affinity and trigger changes that influence the behavior of cells. GABA-A receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to benzodiazepines and barbiturates. GABA-B receptors act through G-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for L-baclofen. GABA Receptors,Receptors, gamma-Aminobutyric Acid,gamma-Aminobutyric Acid Receptors,GABA Receptor,gamma-Aminobutyric Acid Receptor,Receptor, GABA,Receptor, gamma-Aminobutyric Acid,Receptors, gamma Aminobutyric Acid,gamma Aminobutyric Acid Receptor,gamma Aminobutyric Acid Receptors

Related Publications

T Sasaki, and J L Kennedy, and J N Nobrega
November 1986, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
T Sasaki, and J L Kennedy, and J N Nobrega
March 2018, Pharmacology, biochemistry, and behavior,
T Sasaki, and J L Kennedy, and J N Nobrega
October 2014, Progress in neuro-psychopharmacology & biological psychiatry,
T Sasaki, and J L Kennedy, and J N Nobrega
February 2004, Behavioural brain research,
T Sasaki, and J L Kennedy, and J N Nobrega
February 2008, Psychopharmacology,
Copied contents to your clipboard!